Gagnon Securities’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-211,141
| Closed | -$1.29M | – | 115 |
|
|
2021
Q3 | $1.29M | Buy |
211,141
+2,111
| +1% | +$12.9K | 0.19% | 55 |
|
|
2021
Q2 | $1.72M | Buy |
209,030
+1,683
| +0.8% | +$13.8K | 0.24% | 49 |
|
|
2021
Q1 | $1.86M | Buy |
207,347
+7,020
| +4% | +$62.8K | 0.28% | 51 |
|
|
2020
Q4 | $2.31M | Buy |
200,327
+3,245
| +2% | +$37.5K | 0.37% | 44 |
|
|
2020
Q3 | $2.05M | Buy |
197,082
+375
| +0.2% | +$3.9K | 0.44% | 41 |
|
|
2020
Q2 | $2.59M | Sell |
196,707
-528,017
| -73% | -$6.94M | 0.63% | 33 |
|
|
2020
Q1 | $5.7M | Sell |
724,724
-4,654
| -0.6% | -$36.6K | 1.94% | 19 |
|
|
2019
Q4 | $15.1M | Sell |
729,378
-51,033
| -7% | -$1.06M | 3.3% | 10 |
|
|
2019
Q3 | $10.7M | Buy |
780,411
+26,617
| +4% | +$365K | 2.53% | 15 |
|
|
2019
Q2 | $9.27M | Buy |
753,794
+65,523
| +10% | +$806K | 2% | 21 |
|
|
2019
Q1 | $8.59M | Buy |
688,271
+434,448
| +171% | +$5.42M | 1.87% | 23 |
|
|
2018
Q4 | $2.87M | Sell |
253,823
-196,832
| -44% | -$2.23M | 0.76% | 34 |
|
|
2018
Q3 | $8.43M | Buy |
450,655
+59,864
| +15% | +$1.12M | 1.94% | 19 |
|
|
2018
Q2 | $10.1M | Buy |
390,791
+60,796
| +18% | +$1.57M | 2.91% | 14 |
|
|
2018
Q1 | $7.4M | Sell |
329,995
-8,612
| -3% | -$193K | 2.63% | 18 |
|
|
2017
Q4 | $8.48M | Buy |
338,607
+194,276
| +135% | +$4.86M | 3.01% | 14 |
|
|
2017
Q3 | $3.49M | Buy |
+144,331
| New | +$3.49M | 1.3% | 27 |
|